Oral Presentation 1

[OP1-03] Cancer vaccine improves the efficacy of Immune checkpoint blockade against refractory cancers.

*Shohei Ueda^1,2, Miho Ushijima¹, Atsushi Irie², Satoru Senju², Koyu Ito³, Hiroshi Hamana⁴, Hiroyuki Kishi⁵, Koetsu Ogasawara³, Keiko Udaka⁶, Masatoshi Eto¹, Yasuharu Nishimura² (1. Dept. Urology, Grad. Sch. Med. Sci., Kyushu Univ., 2. Dept. Immunology, Grad. Sch. Med. Sci., Kumamoto Univ., 3. Dept. Immunobiology, Inst. Development Aging & Cancer, Tohoku Univ., 4. Dept. Innovative. Cancer Immunotherapy, Sch. Med. Sci., Toyama Univ., 5. Dept. Immunol, Grad. Sch. Med. Pharm. Sci., Toyama Univ., 6. Ctr. Innovative & Translational Med., Grad. Sch. Med. Sci., Kochi,Univ.)